TWD 31.85
(-2.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 2.43 Billion TWD | -27.64% |
2022 | 3.37 Billion TWD | -2.66% |
2021 | 3.46 Billion TWD | -6.45% |
2020 | 3.7 Billion TWD | 15.22% |
2019 | 3.21 Billion TWD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 2.5 Billion TWD | -3.07% |
2024 Q1 | 2.58 Billion TWD | 6.11% |
2023 Q3 | 2.45 Billion TWD | -29.54% |
2023 Q2 | 3.49 Billion TWD | 0.71% |
2023 FY | 2.43 Billion TWD | -27.64% |
2023 Q1 | 3.46 Billion TWD | 0.0% |
2023 Q4 | 2.43 Billion TWD | -0.79% |
2022 Q4 | - TWD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Allied Biotech Corporation | 796.6 Million TWD | -206.281% |
GeneFerm Biotechnology Co., Ltd. | 152.07 Million TWD | -1504.337% |
Easywell Biomedicals, Inc. | 386.34 Million TWD | -531.527% |
TTY Biopharm Company Limited | 1.91 Billion TWD | -27.405% |
Orient EuroPharma Co., Ltd. | 4.84 Billion TWD | 49.615% |
Center Laboratories, Inc. | 5.62 Billion TWD | 56.614% |
Tien Liang BioTech Co., Ltd. | 84.65 Million TWD | -2781.984% |
Orient Pharma Co., Ltd. | 716.92 Million TWD | -240.322% |
InnoPharmax Inc. | 21.49 Million TWD | -11248.709% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 160.83 Million TWD | -1417.033% |
Excelsior Biopharma Inc. | 377.4 Million TWD | -546.483% |
DV Biomed Co., Ltd. | 387.69 Million TWD | -529.323% |
Foresee Pharmaceuticals Co., Ltd. | 228.25 Million TWD | -968.909% |
Handa Pharmaceuticals, Inc. | 13.24 Million TWD | -18327.938% |
UniPharma Co., Ltd. | 277 Thousand TWD | -880715.523% |
Anxo Pharmaceutical Co., Ltd. | 787.84 Million TWD | -209.69% |
Alar Pharmaceuticals Inc. | 1.4 Million TWD | -173062.456% |
Winston Medical Supply Co., Ltd. | 107.32 Million TWD | -2173.252% |
Mercury Biopharmaceutical Corporation | 42.34 Million TWD | -5661.314% |
Bioray Biotech Co., Ltd | 69.79 Million TWD | -3395.901% |
TSH Biopharm Corporation Limited | 7.84 Million TWD | -31008.747% |